Colony Group’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Colony Group's HALO Position: Q3 2023 in Review
Colony Group increased its Halozyme (HALO) stake by 0.01% in Q3 2023, buying an estimated $205 and bringing the position to 80,387 shares worth $3.07M. The position accounts for 0.05% of the portfolio, ranked #281.
Colony Group first reported a position in HALO in Q2 2018 and has held it in 22 quarters since. The position peaked at $4.64M in Q4 2022. 389 funds tracked by Wall St. Rank hold HALO as of Q3 2023.
- Colony Group held 80,387 shares of Halozyme worth $3.07M as of Q3 2023.
- Colony Group bought 5 Halozyme shares in Q3 2023, an estimated $205.
- Halozyme made up 0.05% of Colony Group's portfolio in Q3 2023, its #281 holding.
- Colony Group first reported a position in Halozyme in Q2 2018 and has held it in 22 quarters since.
- Colony Group's Halozyme position peaked at $4.64M in Q4 2022.
- 389 funds tracked by Wall St. Rank held Halozyme as of Q3 2023.
Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.